Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $46.5600 (1.17%) ($45.8300 - $46.5600) on Mon. Oct. 24, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.11% (three month average) | RSI | 76 | Latest Price | $46.5600(1.17%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.8% a day on average for past five trading days. | Weekly Trend | HALO advances 4.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(40%) IFRA(34%) IWM(33%) IWO(33%) IWN(32%) | Factors Impacting HALO price | HALO will decline at least -1.055% in a week (0% probabilities). VIXM(-10%) VXX(-6%) TBT(-3%) UUP(-2%) USO(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.055% (StdDev 2.11%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $45.29(2.8%) | 10 Day Moving Average | $44.42(4.82%) | 20 Day Moving Average | $42.6(9.3%) | To recent high | -10.2% | To recent low | 20.9% | Market Cap | $6.363b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |